Search

Your search keyword '"miR-25-3p"' showing total 129 results

Search Constraints

Start Over You searched for: Descriptor "miR-25-3p" Remove constraint Descriptor: "miR-25-3p" Search Limiters Available in Library Collection Remove constraint Search Limiters: Available in Library Collection
129 results on '"miR-25-3p"'

Search Results

2. MiR-25-3p regulates pulmonary arteriovenous malformation after Glenn procedure in patients with univentricular heart via the PHLPP2-HIF-1α axis.

Catalog

Books, media, physical & digital resources

3. Cold exposure-induced plasma exosomes impair bone mass by inhibiting autophagy.

4. The phosphokinase activity of IRE1ɑ prevents the oxidative stress injury through miR‐25/Nox4 pathway after ICH.

5. Early miR-320b and miR-25-3p miRNA levels correlate with multiple sclerosis severity at 10 years: a cohort study

6. Non-invasive diagnostic potential of salivary miR-25-3p for periodontal disease and osteoporosis among a cohort of elderly patients with type 2 diabetes mellitus

8. Early miR-320b and miR-25-3p miRNA levels correlate with multiple sclerosis severity at 10 years: a cohort study.

9. A functional polymorphism at the miR-25-3p binding site in the 3′-untranslated region of the S1PR1 gene decreases the risk of osteoporosis in Chinese postmenopausal women

10. Non-invasive diagnostic potential of salivary miR-25-3p for periodontal disease and osteoporosis among a cohort of elderly patients with type 2 diabetes mellitus.

11. Downregulation of miR-25-3p and Its Impact on PTAFR and IGF2BP3 Expression in Type 2 Diabetes Mellitus: Implications for Biomarker Discovery and Disease Pathogenesis.

12. miR-25-3p protects renal tubular epithelial cells from apoptosis induced by renal IRI by targeting DKK3

13. The Relationship and Expression of miR-451a , miR-25-3p and PTEN in Early Peritoneal Endometriotic Lesions and Their Modulation In Vitro.

14. LncRNA CBR3-AS1 regulates of breast cancer drug sensitivity as a competing endogenous RNA through the JNK1/MEK4-mediated MAPK signal pathway

15. MiR-25-3p Serves as an Oncogenic MicroRNA by Downregulating the Expression of Merlin in Osteosarcoma

16. LncRNA JPX promotes cervical cancer progression by modulating miR-25-3p/SOX4 axis

17. LncRNA SNHG12 alleviates hypertensive vascular endothelial injury through miR‐25‐3p/SIRT6 pathway.

18. miR-25-3p promotes proliferation and inhibits autophagy of renal cells in polycystic kidney mice by regulating ATG14-Beclin 1

19. LncRNA FOXD2-AS1 Regulates miR-25-3p/Sema4c Axis To Promote The Invasion And Migration Of Colorectal Cancer Cells

20. ACOX1, regulated by C/EBPα and miR-25-3p, promotes bovine preadipocyte adipogenesis.

21. A feature-based analysis identifies COL1A2 as a regulator in pancreatic cancer

22. LncRNA CBR3-AS1 regulates of breast cancer drug sensitivity as a competing endogenous RNA through the JNK1/MEK4-mediated MAPK signal pathway.

23. Potential of miR-25-3p in protection of chondrocytes: emphasis on osteoarthritis.

24. miR-25-3p promotes proliferation and inhibits autophagy of renal cells in polycystic kidney mice by regulating ATG14-Beclin 1.

25. LncRNA JPX promotes cervical cancer progression by modulating miR-25-3p/SOX4 axis.

26. Exosomes secreted by chronic hepatitis B patients with PNALT and liver inflammation grade ≥ A2 promoted the progression of liver cancer by transferring miR‐25‐3p to inhibit the co‐expression of TCF21 and HHIP.

27. Hsa_circ_0043265 Suppresses Proliferation, Metastasis, EMT and Promotes Apoptosis in Non-Small Cell Lung Cancer Through miR-25-3p/FOXP2 Pathway.

28. MiR-25-3p promotes the proliferation of triple negative breast cancer by targeting BTG2

29. A feature-based analysis identifies COL1A2 as a regulator in pancreatic cancer.

30. LncRNA OIP5-AS1 accelerates intervertebral disc degeneration by targeting miR-25-3p

32. miR-25-3p, Positively Regulated by Transcription Factor AP-2α, Regulates the Metabolism of C2C12 Cells by Targeting Akt1.

33. ACOX1, regulated by C/EBPα and miR-25-3p, promotes bovine preadipocyte adipogenesis

34. MiR-25-3p promotes the proliferation of triple negative breast cancer by targeting BTG2.

35. A functional polymorphism at the miR-25-3p binding site in the 3′-untranslated region of the S1PR1 gene decreases the risk of osteoporosis in Chinese postmenopausal women.

36. MicroRNA-25-3p promotes cisplatin resistance in Non-small-cell lung carcinoma (NSCLC) through adjusting PTEN/PI3K/AKT route

37. Lnc NR2F1-AS1 Promotes Breast Cancer Metastasis by Targeting the MiR-25-3p/ZEB2 Axis.

38. miR-25-3p reverses epithelial-mesenchymal transition via targeting Sema4C in cisplatin-resistance cervical cancer cells.

39. Plasma microRNAs are associated with acute exacerbation in idiopathic pulmonary fibrosis.

40. Exosomal transfer of miR‑25‑3p promotes the proliferation and temozolomide resistance of glioblastoma cells by targeting FBXW7

41. MiR-25-3p targets PTEN to regulate the migration, invasion, and apoptosis of esophageal cancer cells via the PI3K/AKT pathway

42. MicroRNA-148b-3p and MicroRNA-25-3p are overexpressed in fetuses with late-onset fetal growth restriction

43. MicroRNA‑25‑3p regulates human nucleus pulposus cell proliferation and apoptosis in intervertebral disc degeneration by targeting Bim

44. MiR-25-3p Serves as an Oncogenic MicroRNA by Downregulating the Expression of Merlin in Osteosarcoma

45. A feature-based analysis identifies COL1A2 as a regulator in pancreatic cancer

46. miR-25-3p promotes proliferation and inhibits autophagy of renal cells in polycystic kidney mice by regulating ATG14-Beclin 1

47. miR-25-3p promotes endothelial cell angiogenesis in aging mice via TULA-2/SYK/VEGFR-2 downregulation

48. MiR-25-3p attenuates the proliferation of tongue squamous cell carcinoma cell line Tca8113.

49. CircHSPG2 absence weakens hypoxia-induced dysfunction in cardiomyocytes by targeting the miR-25-3p/PAWR axis.

50. Exosomes secreted by chronic hepatitis B patients with PNALT and liver inflammation grade ≥ A2 promoted the progression of liver cancer by transferring miR-25-3p to inhibit the co-expression of TCF21 and HHIP